Comparing TAP Blocks Bupivacaine, and Placebo for Plane
Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
The study will prospectively compare the analgesic efficacy of TAP blocks with liposomal
bupivacaine, plain bupivacaine, and placebo in patients who are scheduled for major abdominal
surgery. The primary aim is to assess the duration of the local analgesia (determined by
pinprick and cold) in all four quadrants. Comparing opioid consumption and pain scores is a
secondary aim. All aims will be assessed over 72 hours or the duration of hospitalization if
shorter.